Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 73 checked references that resolve
resolves10.1289/ehp.1002326Attention Deficit/Hyperactivity Disorder: A Focused Overview for Children’s Environmental Health Researchers
resolves10.1016/j.pnpbp.2012.10.024Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
resolves10.1186/2040-2392-3-16Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial
resolves10.15585/mmwr.ss6706a1Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014
resolves10.1038/sj.bjp.0704327Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
resolves10.1016/j.jpsychires.2012.08.012Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
resolves10.1002/jat.3631Chronic exposure to cannabidiol induces reproductive toxicity in male Swiss mice
resolves10.1111/jcpt.12179Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
resolves10.1176/appi.ajp.160.6.1041Developmental Neurocircuitry of Motivation in Adolescence: A Critical Period of Addiction Vulnerability
resolves10.1016/j.ridd.2014.12.025ADHD and autistic traits, family function, parenting style, and social adjustment for Internet addiction among children and adolescents in Taiwan: A longitudinal study
resolves10.1007/s00213-014-3478-5Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
resolves10.1177/0269881110379283Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
resolves10.1111/epi.12631Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
resolves10.4236/pp.2015.62010Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using <i>Cannabis</i> Extract Enriched in Cannabidiol
resolves10.1097/CHI.0b013e318189148eChild Versus Family Cognitive-Behavioral Therapy in Clinically Anxious Youth: An Efficacy and Partial Effectiveness Study
resolves10.1007/BF00421075Absence of interaction between δ9-tetrahydrocannabinol (δ9-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice
resolves10.1016/j.yebeh.2015.04.009Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome
resolves10.1073/pnas.1711351114Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
resolves10.1038/tp.2016.169Endocannabinoid signaling in social functioning: an RDoC perspective
resolves10.1007/s00787-014-0576-1Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis
resolves10.1016/j.neuropharm.2015.12.017Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
resolves10.1016/j.pbb.2009.04.010Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
resolves10.1038/npp.2017.40Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model
resolves10.1089/cap.2007.0041Psychopharmacology of Aggression in Children and Adolescents with Autism: A Critical Review of Efficacy and Tolerability
resolves10.1007/s10567-011-0097-0Anxiety Disorders in Children and Adolescents with Autistic Spectrum Disorders: A Meta-Analysis
resolves10.1016/j.pnpbp.2015.06.017Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
resolves10.1007/BF00431467Δ 1-tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters
resolves10.1002/ajmg.a.35754Co‐occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion
resolves10.1038/sj.npp.1300225Chronic Pubertal, but not Adult Chronic Cannabinoid Treatment Impairs Sensorimotor Gating, Recognition Memory, and the Performance in a Progressive Ratio Task in Adult Rats
resolves10.1038/sj.npp.1300634Deficient Social and Play Behavior in Juvenile and Adult Rats after Neonatal Cortical Lesion: Effects of Chronic Pubertal Cannabinoid Treatment
resolves10.1016/j.euroneuro.2006.03.009The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion
resolves10.1111/j.1369-1600.2008.00117.xPRECLINICAL STUDY: Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats
resolves10.1002/ptr.2625Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
resolves10.7812/TPP/16-005Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report
resolves10.1089/cap.2012.0048Long-Term Administration of Intranasal Oxytocin Is a Safe and Promising Therapy for Early Adolescent Boys with Autism Spectrum Disorders
resolves10.1017/S0033291714000762A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations
resolves10.3390/ijms18091916The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
The 15 references without a DOI — listed, not checked
no DOI — not checked10.1016/j.pnpbp.2018.08.030_bb0020
no DOI — not checkedExpert review of neurotherapeutics an update on the comorbidity of ASD and ADHD: a focus on clinical management
no DOI — not checked10.1016/j.pnpbp.2018.08.030_bb0045
no DOI — not checkedChemistry and analysis of phytocannabinoids and other cannabis constituents
no DOI — not checked10.1016/j.pnpbp.2018.08.030_bb0075
no DOI — not checkedMaternal drug abuse and adverse effects on neurobehavior of offspring
no DOI — not checkedCannabis Contaminants - sources, distribution, human toxicity and pharmacologic effects
no DOI — not checkedFDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy, 2018. (Office of the Commissioner).
no DOI — not checkedPsychiatric comorbidity of adults with ASD
no DOI — not checkedCannabidiol provides viable treatment opportunity for multi pleneurological pathologies of autism spectrum disorder
no DOI — not checked10.1016/j.pnpbp.2018.08.030_bb0195
no DOI — not checkedPlasma anandamide concentrations are lower in children with autism spectrum disorder
no DOI — not checked10.1016/j.pnpbp.2018.08.030_bb0245
no DOI — not checked10.1016/j.pnpbp.2018.08.030_bb0270
no DOI — not checkedAutistic spectrum disorders and schizophrenia in the adult psychiatric setting: diagnosis and comorbidity
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.